Reconsidering Adjuvant Immunotherapy for Tuberculosis

This publication has 68 references indexed in Scilit:

• Paradoxical Response to Antituberculous Therapy in Infliximab-Treated Patients with Disseminated Tuberculosis
  Clinical Infectious Diseases, 2005
• Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept
  Alimentary Pharmacology & Therapeutics, 2005
• Aerosolized Gamma Interferon (IFN-γ) Induces Expression of the Genes Encoding the IFN-γ-Inducible 10-Kilodalton Protein but Not Inducible Nitric Oxide Synthase in the Lung during Tuberculosis
  Infection and Immunity, 2004
• Six-month Therapy with Aerosolized Interferon-γ for Refractory Multidrug-Resistant Pulmonary Tuberculosis
  Journal of Korean Medical Science, 2004
• Sputum Cytokine Levels in Patients with Pulmonary Tuberculosis as Early Markers of Mycobacterial Clearance
  Clinical and Vaccine Immunology, 2002
• Effects of 2 Different Anti–Tumor Necrosis Factor–? Agents in a Primate Model of Subcutaneous Abscess Formation
  The Journal of Infectious Diseases, 2002
• Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
  New England Journal of Medicine, 2001
• Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
  Published by Elsevier ,1999
• Evaluation of an Intensive Intermittent‐Induction Regimen and Duration of Short‐Course Treatment for Human Immunodeficiency Virus–Related Pulmonary Tuberculosis
  Clinical Infectious Diseases, 1998
• Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India
  Tubercle, 1983